HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Price Selected Research

azelastine (Optivar)

1/2020Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma.
9/2018Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.
1/2017Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
1/2016Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
4/2015Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
3/2014Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis.
11/2012Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
7/2012MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
5/2012A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Price Research Topics

Disease

122Asthma (Bronchial Asthma)
01/2022 - 01/2002
61Chronic Obstructive Pulmonary Disease (COPD)
04/2022 - 06/2004
22Allergic Rhinitis
01/2021 - 01/2005
17Rhinitis
01/2020 - 02/2006
12Respiratory Tract Infections (Respiratory Tract Infection)
01/2017 - 02/2007
9Type 2 Diabetes Mellitus (MODY)
01/2022 - 07/2007
8Infections
01/2022 - 11/2005
7Brain Diseases (Brain Disorder)
01/2022 - 01/2013
7Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021 - 05/2015
6Inflammation (Inflammations)
01/2022 - 09/2008
6Obstructive Lung Diseases (Obstructive Lung Disease)
11/2019 - 06/2004
5Osteoporosis
01/2022 - 06/2009
5Neoplasm Metastasis (Metastasis)
01/2016 - 11/2004
5Seasonal Allergic Rhinitis (Hay Fever)
04/2015 - 05/2012
4Confusion (Bewilderment)
01/2021 - 12/2009
4Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 11/2004
3Respiratory Tract Diseases (Respiratory Tract Disease)
12/2021 - 07/2014
3Hypoglycemia (Reactive Hypoglycemia)
01/2021 - 05/2015
3Hypoxia (Hypoxemia)
01/2020 - 01/2013
3Hypersensitivity (Allergy)
12/2018 - 01/2014
3Cataract (Cataracts)
11/2018 - 03/2013
3Obesity
11/2018 - 10/2011
3Neoplasms (Cancer)
10/2015 - 08/2002
3Facial Pain (Myofacial Pain)
01/2012 - 06/2008
3Pheochromocytoma
09/2009 - 07/2003
2Heart Diseases (Heart Disease)
04/2022 - 01/2009
2Human Influenza (Influenza)
01/2022 - 05/2009
2Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
01/2021 - 01/2017
2Rhinosinusitis
01/2021 - 06/2008
2Glaucoma
02/2020 - 11/2018
2Ischemia
01/2020 - 01/2019
2Asphyxia (Suffocation)
01/2020 - 01/2013
2Brain Injuries (Brain Injury)
10/2019 - 01/2013
2Cardiovascular Diseases (Cardiovascular Disease)
09/2019 - 11/2018
2Hypothermia
01/2019 - 01/2013

Drug/Important Bio-Agent (IBA)

79Adrenal Cortex Hormones (Corticosteroids)IBA
04/2022 - 09/2003
26Bronchodilator Agents (Bronchodilators)IBA
04/2022 - 12/2005
24Fluticasone (Cutivate)FDA LinkGeneric
01/2020 - 05/2007
17Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 06/2008
15Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2015
15SteroidsIBA
01/2022 - 09/2003
14GoldIBA
09/2019 - 06/2004
13Carbon MonoxideIBA
01/2021 - 02/2006
12Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2013
12Muscarinic AntagonistsIBA
01/2022 - 12/2014
12Pharmaceutical PreparationsIBA
12/2021 - 01/2005
9azelastine (Optivar)FDA LinkGeneric
01/2020 - 05/2012
9Formoterol Fumarate (Oxis)FDA Link
12/2019 - 10/2004
9Beclomethasone (Beclometasone)FDA Link
01/2019 - 01/2002
9Tiotropium Bromide (Spiriva)FDA Link
12/2015 - 08/2006
8Insulin (Novolin)FDA Link
01/2022 - 01/2016
6indacaterolIBA
01/2017 - 11/2011
6Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
01/2017 - 07/2014
6MP29-02IBA
01/2016 - 05/2012
5Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 11/2013
5Blood Glucose (Blood Sugar)IBA
01/2022 - 07/2007
5AllergensIBA
01/2020 - 02/2006
5Fluticasone-Salmeterol Drug Combination (Advair)FDA Link
09/2017 - 05/2007
5Salmeterol Xinafoate (Serevent)FDA Link
01/2017 - 05/2007
5Cholinergic Antagonists (Anticholinergics)IBA
04/2015 - 08/2006
5montelukast (Singulair)FDA Link
10/2014 - 01/2005
43- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA
01/2022 - 01/2009
4DiamondIBA
01/2021 - 01/2017
4SmokeIBA
01/2021 - 03/2014
4MelatoninIBA
02/2020 - 01/2013
4Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
01/2020 - 01/2010
4Histamine Antagonists (Antihistamines)IBA
01/2020 - 06/2008
4Fluorouracil (Carac)FDA LinkGeneric
01/2016 - 11/2004
3insulin receptor-related receptor (IRR)IBA
01/2021 - 10/2014
3Immunoglobulin E (IgE)IBA
01/2020 - 06/2008
3Protons (Proton)IBA
07/2019 - 01/2013
3Theophylline (Theon)FDA LinkGeneric
01/2019 - 06/2015
3GSK573719IBA
01/2017 - 07/2014
3Yttrium-90IBA
01/2016 - 03/2007
3Leucovorin (Folinic Acid)FDA Link
01/2016 - 11/2004
3Albuterol (Salbutamol)FDA LinkGeneric
01/2014 - 06/2008
3apaflurane (hydrofluoroalkane)IBA
07/2013 - 01/2002
2Caspase 3 (Caspase-3)IBA
01/2022 - 01/2013
2Biological ProductsIBA
01/2022 - 11/2019
2Progestins (Progestagens)IBA
01/2021 - 01/2020
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2021 - 01/2018
2Estrogens (Estrogen)FDA Link
01/2021 - 01/2021
2Excipients (Suspending Agents)IBA
01/2020 - 01/2017
2Lactic Acid (Lactate)FDA LinkGeneric
07/2019 - 01/2013
2N-acetylaspartate (N-acetyl aspartate)IBA
07/2019 - 01/2013
2Neuroprotective AgentsIBA
01/2019 - 01/2013
2GlucocorticoidsIBA
01/2018 - 05/2011
2Acetaminophen (Paracetamol)FDA LinkGeneric
01/2018 - 01/2016

Therapy/Procedure

93Therapeutics
01/2022 - 10/2002
42Nebulizers and Vaporizers (Inhaler)
01/2022 - 10/2004
11Drug Therapy (Chemotherapy)
01/2021 - 11/2004
9Dry Powder Inhalers
01/2022 - 04/2008
9Injections
01/2021 - 05/2015
6Induced Hypothermia
01/2022 - 01/2013
6Metered Dose Inhalers (Metered Dose Inhaler)
01/2017 - 01/2010
5Glycemic Control
01/2022 - 01/2003
3Microspheres (Microsphere)
01/2016 - 03/2007
3Complementary Therapies (Alternative Medicine)
05/2006 - 09/2003
2Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2021 - 01/2021
2Biological Therapy
11/2019 - 01/2017